Navigation Links
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Date:1/7/2008

s and factors currently known by Isis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2006, and its quarterly report on Form 10-Q for the quarter ended September 30, 2007, which are on file with the SEC. Copies of these and other documents are available from the Company.

Isis Pharmaceuticals is a registered trademark of Isis Pharmaceuticals, Inc. Ibis Biosciences and Ibis T5000 are trademarks of Ibis Biosciences, Inc. Regulus Therapeutics is a trademark of Regulus Therapeutics LLC.

Conference Call Information

Genzyme and Isis will host a webcast conference call today at 5:15 pm EST (2:15 pm PST) to discuss the transaction. To access the call, log on to either company's web site or dial 888-323-5253 (U.S.) / 210-234-0009 (International) and reference passcode: Genzyme. A replay of the webcast will be available until January 14th by dialing 203-369-3526.

Media Contact, Genzyme Investor Contact, Genzyme

Erin Emlock Sally Curley

(617) 768-6923 (617) 768-6140

Contact, Isis

Kate Corcoran

(760) 603-2712


'/>"/>
SOURCE Genzyme Corp.; Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
2. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
3. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
4. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
5. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
6. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
7. Genzyme Launches Cholestagel(R) in Europe
8. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
9. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
10. Genzyme Recognized by Scientists as a Top Employer
11. Genzyme Receives Approval to Market Elaprase(R) in Japan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCa...calcompanyfocusedondevelopingandcommercializingnov...yDiTonno,PresidentandChiefExecutiveOfficer,issched...Conference,tobeheldDecember1-2,2009atTheNewYorkPal...henGhiglieri,ChiefFinancialOfficer,willbeavailable...
(Date:11/24/2009)..., The FBI recently approv...aboratories participating in or generating DNA rec... Madison, WI USA (PRWEB) -- The FB... HS System for use by laboratories participating ...A Index System (NDIS). NDIS currently contains mor...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--...tybiopharmaceuticalcompany,today,announcedthatitha...glucerasealfa,thecompany,senzymereplacementtherapy....Thisisthethirdmarketing,applicationforvelaglucera...sintheUnitedStatesandCanada. , Basedonaglobal...
(Date:11/24/2009)...,, BOZEN,Italy,November24/PRNewswire/--Healt...njointventurewithagroupofselected,investors.Thisre...e,nameHealthRoboticsCanada,Inc.andwillmarket,insta...ncept,whichincludesthe,revolutionaryproductofferin...oboticsCanadaInc.willalsoprovideassistanceonan"asn...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...Scientific Protein Laboratories , a producer of ac...d by New York-based Arsenal Capital Partners . ,A...cialty chemicals and healthcare companies announce... today. , ,SPL, based in Waunakee, Wis., is the wo...which is used to manufacture anticoagulants used i...
...will assume duties as director of the state Depar...mmerce Secretary Cory Nettles announced the hire... initiative. , ,Part of the key to our successful...ity really lie in collaborative efforts. We hope t...ested in starting technology businesses to the rig...
... dream of competing together to race the fastest c... group of 20 engineers, scientists and technicians...sed Oshkosh Truck , the goal is to win the $1 mil...he DARPA Grand Challenge . , ,The Defense Advanc...ional mandate to reward advanced technology achiev...
Other Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 3
(Date:11/24/2009)... ROUGE Antarctica has long held secrets of the ea...recently, there has been very little information o...iles of ice for millions of years. Now, a team of ... have been funded to the tune of $10 million dolla...get to the bottom of things literally. These scie...
(Date:11/23/2009)...ton, D.C. The community-associated strain of the ...resistant to most common antibioticsposes a far gr...aking its way into hospitals, according to a study...eases . , The new threat is easily picked up in... and has increased the overall burden of MRSA with...
(Date:11/23/2009)...ton, CT Current research suggests that a common o...The related report by Nichols et al, "Unique Lipid...ass of TLR2 Ligands Capable of Enhancing Autoimmun...merican Journal of Pathology . , Multiple sclero...s the brain and spinal cord, affects nearly 1 in 7...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2URAC Seeks Public Input on New Uniform External Review Standards for Health Plan and Health Utilization Management Organizations 51887 1URAC Seeks Public Input on New Uniform External Review Standards for Health Plan and Health Utilization Management Organizations 51887 2URAC Seeks Public Input on New Uniform External Review Standards for Health Plan and Health Utilization Management Organizations 51887 3Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel 28R 29 51884 1Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 1Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 2Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 3Biostar Pharmaceuticals Inc Receives Government Approvals for Three New Products 51881 4
...ey bees, neuropeptides control brain activity and,...se peptides play in the life of a honey bee will a...play in their human counterparts. , There are a mi...llifera), a brain not much larger than the size of...ities of these neurons are influenced by the sea o...
...ge are central to our forest sector, according to ... Honourable Gary Lunn, Minister of Natural Resourc...nal Forest Congress. , "The report,s theme of ind...er Lunn. "Canada,s forest industry has reacted dec...llenges of a changing marketplace. It continues to...
...st identified in a cabbage-eating moth may one day...iruses for gene therapy, researchers say. , , Th...ized jumping genes, or transposons, to insert them...nge, such as making the cell resistant to damage f... transposon was five to 10 times better than the o...
Other Biology News:Scientists identify 36 genes, 100 neuropeptides in honey bee brains 2Report highlights change in Canada's forests 2Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3
ExcelGel DNA Analysis Kit from GE Healthcare, formerly Amersham Biosciences
Canine IFN-gamma ELISA Kit from R&D Systems
Bovine Serum Albumin Peroxidase Stabilizer Solution from BioFX Laboratories, Inc.
...zyme is an agarose-digesting enzyme isolated from ...le carbohydrate bonds in agarose producing carbohy...ing carbohydrate molecules will not interfere with...lzyme enzyme can be used for restriction endonucle...
Biology Products: